MedTech I.Q.

The Cutting Edge of Medical Technology Content, Community & Collaboration

6-Hour Virtual Seminar on FDA Scrutiny of Promotion and Advertising Practices

Event Details

6-Hour Virtual Seminar on FDA Scrutiny of Promotion and Advertising Practices

Time: June 22, 2021 from 8am to 2pm
Location: Online event
Street: Online event
City/Town: Fremont
Website or Map: https://www.gcplearning.com/v…
Phone: 8004479407
Event Type: online, event
Organized By: John Robinson
Latest Activity: May 21

Export to Outlook or iCal (.ics)

Event Description

If you go "off label" with advertising and promotion, FDA's hammer can hit hard and seemingly out of the blue.

Advertising and promotion for devices is weak and lacks legal clarity. For drugs, the regulations are prescriptive and guidance documents clamp down on nuances. Marketing and regulatory affairs departments must collaborate to avoid the hammer and penalties of FDA. The roadblock, however is that marketing managers and regulatory affairs managers rarely reach common ground and are loathe to even consult with each other.

FDA's Center for Devices and Radiological Health (CDRH) has never issued a comprehensive guidance on advertising and promotion. You are on your own. In contrast, FDA's Center for Drug Evaluation and Research (CDER) uses long-standing regulations and a growing number of guidance documents in its regulatory approach. Policing social media has become a new regulatory responsibility and FDA is still trying to figure out how to deal with it. Bottom line, do you know when you fail to meet FDA's requirements or are you guessing? Can you afford to guess? The cost to your business and the confusion left in your customers' mind becomes an unwelcomed nightmare.

Comment Wall

Comment

RSVP for 6-Hour Virtual Seminar on FDA Scrutiny of Promotion and Advertising Practices to add comments!

Join MedTech I.Q.

Attending (1)

© 2021   Created by CC-Conrad Clyburn-MedForeSight.   Powered by

Badges  |  Report an Issue  |  Terms of Service